Locking element for vascular closure device

Information

  • Patent Grant
  • 9913634
  • Patent Number
    9,913,634
  • Date Filed
    Friday, February 20, 2009
    17 years ago
  • Date Issued
    Tuesday, March 13, 2018
    8 years ago
Abstract
In one illustrative example, a device for sealing an opening in a vessel wall and/or tissue tract may include an anchor, a filament, a plug, and a knot. The anchor may be configured to be disposed adjacent to an interior surface of the vessel wall adjacent the opening in the vessel wall. The filament may have a distal end coupled to the anchor and may be configured to extend proximally through the vessel opening and/or tissue tract. The plug may be disposed about at least a portion of the filament member. The knot may be disposed about the filament proximal of the plug and may be configured to move over the filament and secure the plug relative to the anchor. The knot may be independent of the filament member.
Description
FIELD

The present disclosure relates generally to medical devices and more particularly to methods and devices for closing and/or sealing punctures in tissue.


BACKGROUND

In many medical procedures, such as, for example, balloon angioplasty and the like, an opening can be created in a blood vessel or arteriotomy to allow for the insertion of various medical devices which can be navigated through the blood vessel to the site to be treated. For example, a guidewire may first be inserted through the tissue tract created between the skin, or the epidermis, of the patient down through the subcutaneous tissue and into the opening formed in the blood vessel. The guidewire is then navigated through the blood vessel to the site of the occlusion or other treatment site. Once the guidewire is in place, an introducer sheath can be slid over the guide wire to form a wider, more easily accessible, tract between the epidermis and the opening into the blood vessel. The appropriate medical device can then be introduced over the guidewire through the introducer sheath and then up the blood vessel to the site of the occlusion or other treatment site.


Once the procedure is completed, the medical devices or other equipment introduced into the vessel can be retracted through the blood vessel, out the opening in the blood vessel wall, and out through the tissue tract to be removed from the body. The physician or other medical technician is presented with the challenge of trying to close the opening in the blood vessel and/or the tissue tract formed in the epidermis and subcutaneous tissue. A number of different device structures, assemblies, and methods are known for closing the opening in the blood vessel and/or tissue tract, each having certain advantages and disadvantages. However, there is an ongoing need to provide new and improved device structures, assemblies, and/or methods for closing and/or sealing the opening in the blood vessel and/or tissue tract.


BRIEF SUMMARY

The following summary is provided to facilitate an understanding of some of the innovative features unique to the present disclosure and is not intended to be a full description. A full appreciation of the disclosure can be gained by taking the entire specification, claims, drawings, and abstract as a whole.


The present disclosure relates generally to medical devices and more particularly to methods and devices for closing and/or sealing punctures in tissue. In one illustrative embodiment, a device for sealing an opening in a vessel wall and/or tissue tract may include an anchor, a filament, a plug, and a knot. The anchor may be configured to be disposed adjacent to an interior surface of the vessel wall adjacent the opening in the vessel wall. The filament may have a distal end coupled to the anchor and may be configured to extend proximally through the vessel opening and/or tissue tract. The plug may be disposed about at least a portion of the filament member. The knot may be disposed about the filament proximal of the plug and may be configured to move over the filament and secure the plug relative to the anchor. The knot may be independent of the filament member.


In some cases, the knot may include a suture member having a first end, a second end, and an intermediate portion having a number of turns defining a lumen, wherein the first end and second end are passed through the lumen. In some cases, the knot may be configured to exert a compressive force on the filament.





BRIEF DESCRIPTION OF THE DRAWINGS

The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:



FIG. 1 is a schematic diagram of an illustrative embodiment of an anchor, a plug, a filament, and a locking element for closing and/or sealing an opening in a blood vessel and/or adjacent tissue tract;



FIG. 2 is a schematic diagram of the illustrative knot of FIG. 1 loosely disposed about the filament shown in FIG. 1;



FIG. 3 is a schematic diagram of the illustrative knot of FIG. 1 tightly disposed about the filament shown in FIG. 1; and



FIGS. 4 and 5 are schematic diagrams of an illustrative embodiment of a device for sliding the knot along the filament to deploy the plug within the opening of the vessel wall and/or tissue tract.





While the invention is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention.


DETAILED DESCRIPTION

For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.


All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.


The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).


As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.


The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.



FIG. 1 is a schematic diagram of an illustrative embodiment of an anchor 10, a plug 12, a filament 14, and a locking element 16 for closing and/or sealing an opening in a blood vessel 30 and/or adjacent tissue tract 34 that was created to gain access to the vessel to perform a medical procedure. In the illustrative embodiment, the anchor 10 may be configured to engage an interior surface of the vessel wall 32. In some cases, the anchor 10 may be configured to partially or completely occlude the opening in the vessel wall 32, as desired. The anchor 10 may include a biodegradable material so that, over time, the anchor 10 is degraded, eroded, and/or absorbed in the body. In some cases, the anchor 10 may include a PLGA, PLLA, PGA or other degradable or erodable polymers, such as polyesters, polysaccharides, polyanhydrides, polycaprolactone, and various combinations thereof. In some cases, the anchor 10 may include a combination of the previously mentioned materials to impart a variable strength and/or degradation time profile in the anchor 10. One example anchor 10 that is configured to rapidly absorb and/or degrade is disclosed in Application Ser. No. 61/031,456, filed Feb. 26, 2008, which is hereby incorporated by reference. However, it is contemplated that any suitable anchor 10 may be used, as desired.


Filament 14 may include a proximal end, a distal end, with a length extending therebetween. The distal end of the filament 14 may be coupled to the anchor 10 with the filament 14 extending proximally therefrom and through the tissue tract 34. In some cases, the anchor 10 may include a raised portion including an eyelet to facilitate attachment of the distal end of the filament 14 to the anchor. In other cases, the distal end of the filament 14 may be molded into the anchor 10, passed through an opening in the anchor 10, or otherwise attached, connected, or secured to the anchor 10, as desired.


The filament 14 may include a biodegradable material so that, over time, the filament 14 is degraded, eroded, and/or absorbed in the body. In some cases, the filament 14 may include a PLGA, PLLA, PGA or other degradable or erodable polymers, such as polyesters, polysaccharides, polyanhydrides, polycaprolactone, and various combinations thereof. In some cases, the filament 14 can include a suture material, which may be a biodegradable suture.


In the illustrative embodiment, the plug 12 can be disposed about at least a portion of the filament 14 adjacent to the anchor 10 in the tissue tract 34 and/or opening of the vessel wall 32. The plug 12 may be configured to fill the space in the tissue tract 22 adjacent to the vessel 30 and/or the opening in the vessel wall 32 to close and/or seal the vessel 30 opening and/or tissue tract 34. In some example, the plug 12 may include a material that swells to fill space in the tissue tract 34 and/or vessel wall 32 opening, such as by elastic expansion, fluid absorption, chemical reaction, as well as any other suitable swelling and/or expansion. The plug 12 can be configured to promote hemostasis and/or clotting adjacent to the vessel 30. In one example, the plug may include a collagen, gelatin foam, PEG, starch powder, any suitable hemostatic material, any suitable clot-promoting material, as well as any other suitable material, as desired. In some cases, other materials can be used to provide control of thrombogenicity or hydration. The plug 12 may include a biodegradable material so that, over time, the plug 12 is degraded, eroded, and/or absorbed in the body.


In the illustrative embodiment, the plug 12 may be generally cylindrical in shape with a lumen extending therethrough. As illustrated, the plug 12 is shown in an axially compressed state after it has been deployed in the tissue tract 20.


Some examples of plugs and plug materials that may be used in the closure device are disclosed in application Ser. No. 12/390,289, filed on the even date herewith, which is hereby incorporated by reference. In some cases, the plug 12 can include one or more voids, notches, slits, or other modifications to provide a desired axial compression of plug 12. Examples of plugs that may include voids, notches, slits, or other modification are disclosed in application Ser. No. 12/389,960, filed on the even date herewith, which is hereby incorporated by reference. In some cases, the illustrative plug 12 can be processed to have desired expansion characteristics. For example, the plug 12 can be tenderized to break down cell walls to increase the rate of expansion of the plug 12. Examples of plugs that have been tenderized or otherwise processed and methods of tenderizing or otherwise processing are disclosed in application Ser. No. 12/390,067, filed on the even date herewith, which is hereby incorporated by reference.


In the illustrative embodiment, the locking element 16 can be a knot. The knot 16 can be used to help secure the plug 12 relative to the anchor 10. In one example, a knot 16 can be disposed about at least a portion of the filament 14 proximal of the anchor 10. The knot 16 can be configured to slide over the filament 14 and compress the plug 12. In some cases, the knot 16 can be slide distal over the filament 14 to compress the plug 12. In some cases, the knot 16 may be a compression knot exerting a radial force on the filament 14. As such, the knot 16 may be configured to have a corresponding friction force of 0.5 pounds, 1.0 pound, 1.5 pounds, 2.0 pounds, 2.5 pounds, 3.0 pounds, or any other friction force, as desired. For example, the knot 16 may have a friction force of at least 0.5 pounds. In another example, the knot 16 may have a friction force of at least one pound, two pounds, three pounds, or any other friction force, as desired. In any event, the knot 16 may be configured to have a friction force greater than the rebound force of the plug 12 to prevent the plug 12 expanding after compression. The rebound force of the plug 12 may be the force of the plug 12 trying to expand in the axial direction after compression.


In the illustrative embodiment, the knot 16 may be independent of the filament 14. The knot 16 may include a suture that is independent of the filament 14. In some cases, the knot 16 may be include a suture that has a larger radial diameter than the filament 14 so that the knot 16 has a sufficient size to contact the proximal end of the plug 12 for axial compression and not penetrating into the plug 12.


In the illustrative embodiment, the knot 16 may include a degradable material so that over time, it is degraded or eroded and no longer present in the body. In some cases, the locking element 16 may include a PLGA, PLLA, PGA or other degradable or erodable polymers, such as polyesters, polysaccharides, polyanhydrides, polycaprolactone, and various combinations thereof.



FIGS. 2 and 3 are schematic diagrams of the illustrative knot 16 of FIG. 1 disposed about the filament 14. As shown in FIG. 2, the knot 16 can be formed by loosely wrapping a suture 17 around the filament 14 a number of times to define a lumen therethrough. As illustrated in FIG. 2, the suture 17 can be wrapped around the filament 14 five times. However, it is contemplated that the suture 17 may be wrapped around the filament 14 one time, two times, three times, four times, five times, six times, seven times, eight times, nine times, ten times, or any number of times, as desired. Then, both ends of the suture 17 may be passed through the lumen defined by the turns of the knot 16.


Suture 17 ends can then by pulled to tighten the knot 16 as shown in FIG. 3. In other words, a tensioning force can be applied to the ends of the suture 17 to tighten the knot 16. The tensioning force to tighten the knot 16 may correspond to the compressive force that the knot 16 exerts on the filament. For example, the greater the tensioning force, the greater the compressive force exerted by the knot 16 on the filament 14. With the knot 16 tightly tied, the ends of the suture 17 can be removed from the knot 16.


In the illustrative embodiment, the suture 17 of knot 16 may be separate and distinct from the filament 17. In other words, the knot 16 may be independent of the filament 14. Further, in some cases, the knot 16 may be constructed of a suture 17 that is has a different radial diameter than the suture used for the filament 14. In one illustrative example, the filament 14 may have a diameter of about 0.014 to 0.016 millimeters and the suture 17 of the knot 16 may have a diameter of about 0.016 to 0.018 millimeters. However, it is contemplated that any combination of suture sizes may be used, as desired. In this illustrative example and when five turns are used, the length of the knot 16 may be about 0.0890 to 0.091 millimeters. In addition, in this example, the diameter of the loose knot 16 may be about 0.069 millimeters and the diameter of the tight knot 16 may be about 0.0511 to 0.0532 millimeters. However, any suitable length or width may be used, as desired.



FIGS. 4 and 5 are schematic diagrams of an illustrative embodiment of a device for sliding the knot 16 along the filament 14 to deploy the plug 12 within the opening of the vessel wall 32 and/or tissue tract 34. In the illustrated embodiment, an insertion sheath 18 may be disposed at least partially in the tissue tract 34 for providing access to the opening in the vessel wall 32. The device for delivery the anchor 10, plug 12, filament 14, and knot 16 can include a device sheath 20 configured to pass into the insertion sheath 18. As shown, the device may include a push rod 22 having a distal end coupled to a plunger compression bead 24. The plunger compression bead 24 may be disposed adjacent to the knot 16. In the illustrative example, the push rod 22 can include one or more coils configured to slide over the filament 14.


In the illustrative example, the device may include an automatic filament release mechanism. This mechanism may include a collet 36 coupled to the filament 14 and a collet locking ring 38 configured to releasably engage the filament 14. As the push rod 22 is advanced distally, a filament release bead 40 disposed in the push rod 22 and about the collet 36, may be advanced distally over the collet 36 and engage the collet locking ring 38. As the push rod 22 continues to advance distally, the filament release bead 40 may disengage the collet locking ring 38 from the collet 36 releasing the filament 14 from the device. An example of an implantation device that may be used with the illustrative anchor 10, plug 12, filament 14, and knot 16 is disclosed in application Ser. No. 12/390,241, filed on the even date herewith, which is hereby incorporated by reference.


As illustrated in FIG. 4, the anchor 10 is seated against the interior of the vessel wall 32 or arteriotomy. The filament 14 is coupled to the anchor 10 and extends proximally through the tissue tract 34. The plug 12 is disposed over the filament 14 adjacent the anchor 10 and the knot 16 is disposed about the filament 14 proximal of the plug 12. The plug 12, filament 14, and knot 16 may be disposed, at least partially, within the device sheath 20. As illustrated, both the insertion sheath 18 and the device sheath 20 may be retracted a distance from the anchor 10 and/or opening in the vessel wall 32 to provide an area for plug 12 deployment. In the illustrative example, the distance may be about one-quarter the length of the plug 12. However, it is contemplated that any suitable distance may be used, as desired.



FIG. 5 shows the plug 12 in a compressed state after the device has been actuated advancing the push rod 22 to slide the knot 16 distally over the filament 14 and compress the plug 12. As discussed previously, the knot 16 may have a friction force on the filament 14, which may be greater than the rebound force of the plug 12. The force exerted by the push rod 22 and plunger compression bean 24 on the knot 16 may be greater than the friction force of the knot 16. As such, the knot 16 can maintain the plug 12 in a compressed state when the device, including the push rod 22, plunger compression bead 24, device sheath 20, and insertion sheath are removed. With the device and insertion sheath 18 removed, the anchor 10, plug 12, filament 14, and knot 16 may remain in the tissue tract 34 and/or vessel wall 32 opening, as shown in FIG. 1.


It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the invention. The invention's scope is, of course, defined in the language in which the appended claims are expressed.

Claims
  • 1. A device for sealing an opening in a vessel wall and/or tissue tract, the device comprising: an anchor member configured to be disposed adjacent to an interior surface of the vessel wall adjacent the opening in the vessel wall;a filament member having a distal end coupled to the anchor member and configured to extend proximally through the vessel opening and/or tissue tract;a plug member disposed about at least a portion of the filament member and in direct contact with the anchor member; anda knot member disposed and tightened about the filament member proximal of the plug member, wherein the tightened knot member is configured to move over the filament member and axially compress the plug member against the anchor member, wherein the knot member is independent of the filament member;wherein the knot member includes a first suture having a diameter larger than a diameter of the filament member.
  • 2. The device of claim 1, wherein the filament member includes a second suture.
  • 3. The device of claim 1 wherein the knot member exerts a compressive force on the filament member.
  • 4. The device of claim 3 wherein the compressive force of the knot member on the filament member correlates to a friction force that is greater than a rebound force of the plug member, wherein the rebound force of the plug is a force of the plug trying to expand in the axial direction after compression.
  • 5. The device of claim 3 wherein the knot member has a friction force of at least 0.5 pounds.
  • 6. The device of claim 3 wherein the knot member has a friction force of at least two pounds.
  • 7. A device for sealing an opening in a vessel wall and/or tissue tract, the device comprising: a biodegradable anchor member configured to be disposed adjacent to an interior surface of the vessel wall adjacent the opening in the vessel wall;a first suture member having a distal end coupled to the anchor member and configured to extend proximally through the vessel opening and/or tissue tract;a plug member disposed about at least a portion of the first suture member adjacent to and in direct contact with the anchor member; anda second suture member includes a first end, a second end, and an intermediate portion having a number of turns defining a lumen, wherein the first end and second end are passed through the lumen, wherein the second suture member is disposed and tightened about the first suture member proximal of the plug member, wherein the second suture member exerts a compressive force on the first suture member, wherein the second suture member is independent of the first suture member;wherein the second suture member has a diameter that is larger than the first suture member;wherein the second suture member is configured to move over the first suture member and axially compress the plug member against the anchor member.
  • 8. The device of claim 7 wherein the compressive force of the second suture member on the first suture member is related to a friction force of the second suture, wherein the friction force of the second suture is greater than a rebound force of the plug member, wherein the rebound force of the plug is a force of the plug trying to expand in the axial direction after compression.
  • 9. The device of claim 8 wherein the second suture member has a friction force of at least two pounds.
  • 10. The device of claim 8 further comprising a push rod configured to exert a force on the second suture member greater than the friction force of the second suture member on the first suture member.
US Referenced Citations (222)
Number Name Date Kind
3738692 Martuch et al. Jun 1973 A
5021059 Kensey et al. Jun 1991 A
5108421 Fowler Apr 1992 A
5129882 Weldon et al. Jul 1992 A
5192300 Fowler Mar 1993 A
5192302 Kensey et al. Mar 1993 A
5221259 Weldon et al. Jun 1993 A
5222974 Kensey et al. Jun 1993 A
5254105 Haaga Oct 1993 A
5275616 Fowler Jan 1994 A
5282827 Kensey et al. Feb 1994 A
5290310 Makower et al. Mar 1994 A
5292332 Lee Mar 1994 A
5310407 Casale May 1994 A
5312435 Nash et al. May 1994 A
5320639 Rudnick Jun 1994 A
5342393 Stack Aug 1994 A
5350399 Erlebacher et al. Sep 1994 A
5370660 Weinstein et al. Dec 1994 A
5383896 Gershony et al. Jan 1995 A
5383899 Hammerslag Jan 1995 A
5391183 Janzen et al. Feb 1995 A
5411520 Nash et al. May 1995 A
5413571 Katsaros et al. May 1995 A
5415657 Taymor-Luria May 1995 A
5419765 Weldon et al. May 1995 A
5437631 Janzen Aug 1995 A
5441517 Kensey et al. Aug 1995 A
5443481 Lee Aug 1995 A
5447502 Haaga Sep 1995 A
5454833 Boussignac et al. Oct 1995 A
5478326 Shiu Dec 1995 A
5478352 Fowler Dec 1995 A
5486195 Myers et al. Jan 1996 A
5529577 Hammerslag Jun 1996 A
5531759 Kensey et al. Jul 1996 A
5540715 Katsaros et al. Jul 1996 A
5545178 Kensey et al. Aug 1996 A
5549633 Evans et al. Aug 1996 A
5571181 Li Nov 1996 A
5573518 Haaga Nov 1996 A
5591204 Janzen et al. Jan 1997 A
5593422 Muijs Van de Moer et al. Jan 1997 A
5601602 Fowler Feb 1997 A
5613974 Andreas et al. Mar 1997 A
5620461 Muijs Van De Moer et al. Apr 1997 A
5626601 Gershony et al. May 1997 A
5630833 Katsaros et al. May 1997 A
5649959 Hannam et al. Jul 1997 A
5653730 Hammerslag Aug 1997 A
5662681 Nash et al. Sep 1997 A
5676689 Kensey et al. Oct 1997 A
5700277 Nash et al. Dec 1997 A
5707393 Kensey et al. Jan 1998 A
5716375 Fowler Feb 1998 A
5725498 Janzen et al. Mar 1998 A
5725551 Myers et al. Mar 1998 A
5728114 Evans et al. Mar 1998 A
5728122 Leschinsky et al. Mar 1998 A
5728133 Kontos Mar 1998 A
5728134 Barak Mar 1998 A
5741223 Janzen et al. Apr 1998 A
5782860 Epstein et al. Jul 1998 A
5810884 Kim Sep 1998 A
5830130 Janzen et al. Nov 1998 A
5843124 Hammerslag Dec 1998 A
5853421 Leschinsky et al. Dec 1998 A
5861004 Kensey et al. Jan 1999 A
5871474 Hermann et al. Feb 1999 A
5871501 Leschinsky et al. Feb 1999 A
5906631 Imran May 1999 A
5916236 Muijs Van de Moer et al. Jun 1999 A
5922009 Epstein et al. Jul 1999 A
5935147 Kensey et al. Aug 1999 A
5947997 Pavcnik et al. Sep 1999 A
5948425 Janzen et al. Sep 1999 A
5951583 Jensen et al. Sep 1999 A
5957952 Gershony et al. Sep 1999 A
6007561 Bourque et al. Dec 1999 A
6017359 Gershony et al. Jan 2000 A
6045569 Kensey et al. Apr 2000 A
6045570 Epstein et al. Apr 2000 A
6048357 Kontos Apr 2000 A
6048358 Barak Apr 2000 A
6054569 Bennett et al. Apr 2000 A
6056768 Cates et al. May 2000 A
6056769 Epstein et al. May 2000 A
6056770 Epstein et al. May 2000 A
6080183 Tsugita et al. Jun 2000 A
6110184 Weadock Aug 2000 A
6120524 Taheri Sep 2000 A
6126675 Shchervinsky et al. Oct 2000 A
6162240 Cates et al. Dec 2000 A
6179863 Kensey et al. Jan 2001 B1
6183496 Urbanski Feb 2001 B1
6190400 Van De Moer et al. Feb 2001 B1
6261309 Urbanski Jul 2001 B1
6296632 Luscher et al. Oct 2001 B1
6296657 Brucker Oct 2001 B1
6296658 Gershony et al. Oct 2001 B1
6325789 Janzen et al. Dec 2001 B1
6350274 Li Feb 2002 B1
6368300 Fallon et al. Apr 2002 B1
6368341 Abrahamson Apr 2002 B1
6425911 Akerfeldt et al. Jul 2002 B1
6461346 Buelna Oct 2002 B1
6464712 Epstein et al. Oct 2002 B1
6468293 Bonutti et al. Oct 2002 B2
6475177 Suzuki Nov 2002 B1
6475230 Bonutti et al. Nov 2002 B1
6500152 Illi Dec 2002 B1
6508828 Akerfeldt et al. Jan 2003 B1
6524328 Levinson Feb 2003 B2
6527734 Cragg et al. Mar 2003 B2
6537299 Hogendijk et al. Mar 2003 B1
6540735 Ashby et al. Apr 2003 B1
6569187 Bonutti et al. May 2003 B1
6572635 Bonutti Jun 2003 B1
6592608 Fisher et al. Jul 2003 B2
6596012 Akerfeldt et al. Jul 2003 B2
6596014 Levinson et al. Jul 2003 B2
6613070 Redmond et al. Sep 2003 B2
6623509 Ginn Sep 2003 B2
6632238 Ginn et al. Oct 2003 B2
6656207 Epstein et al. Dec 2003 B2
6663655 Ginn et al. Dec 2003 B2
6682489 Tenerz et al. Jan 2004 B2
6685727 Fisher et al. Feb 2004 B2
6699261 Cates et al. Mar 2004 B1
6712837 Åkerfeldt et al. Mar 2004 B2
6733515 Edwards et al. May 2004 B1
6743195 Zucker Jun 2004 B2
6749621 Pantages et al. Jun 2004 B2
6764500 Muijs Van De Moer et al. Jul 2004 B1
6780197 Roe et al. Aug 2004 B2
6790220 Morris et al. Sep 2004 B2
6818008 Cates et al. Nov 2004 B1
6860895 Akerfeldt et al. Mar 2005 B1
6863680 Ashby Mar 2005 B2
6890342 Zhu et al. May 2005 B2
6890343 Ginn et al. May 2005 B2
6896692 Ginn et al. May 2005 B2
6929655 Egnelov et al. Aug 2005 B2
6939363 Åkerfeldt Sep 2005 B2
6942684 Bonutti Sep 2005 B2
6955683 Bonutti Oct 2005 B2
6964658 Ashby et al. Nov 2005 B2
6969397 Ginn Nov 2005 B2
7001398 Carley et al. Feb 2006 B2
7008439 Janzen et al. Mar 2006 B1
7008440 Sing et al. Mar 2006 B2
7008441 Zucker Mar 2006 B2
7008442 Brightbill Mar 2006 B2
7025776 Houser et al. Apr 2006 B1
7037323 Sing et al. May 2006 B2
7044916 Tenerz et al. May 2006 B2
7083635 Ginn Aug 2006 B2
7192436 Sing et al. Mar 2007 B2
7267679 McGuckin, Jr. et al. Sep 2007 B2
7316704 Bagaoisan et al. Jan 2008 B2
7322976 Yassinzadeh Jan 2008 B2
7331979 Khosravi et al. Feb 2008 B2
7331981 Cates et al. Feb 2008 B2
7335220 Khosravi et al. Feb 2008 B2
20020002889 Ashby et al. Jan 2002 A1
20020016612 Ashby et al. Feb 2002 A1
20020198562 Akerfeldt et al. Dec 2002 A1
20030088271 Cragg et al. May 2003 A1
20040093025 Egnelov May 2004 A1
20040098044 Van de Moer et al. May 2004 A1
20040098046 Tenerz et al. May 2004 A1
20040133236 Chanduszko Jul 2004 A1
20040172059 Tenerz et al. Sep 2004 A1
20040204741 Egnelov et al. Oct 2004 A1
20040215232 Belhe et al. Oct 2004 A1
20040243007 Tenerz et al. Dec 2004 A1
20050049637 Morris et al. Mar 2005 A1
20050085852 Ditter Apr 2005 A1
20050085855 Forsberg Apr 2005 A1
20050096696 Forsberg May 2005 A1
20050096697 Forsberg et al. May 2005 A1
20050107827 Paprocki May 2005 A1
20050125031 Pipenhagen et al. Jun 2005 A1
20050137624 Fallman Jun 2005 A1
20050169974 Tenerz et al. Aug 2005 A1
20050177189 Ginn et al. Aug 2005 A1
20050267521 Forsberg Dec 2005 A1
20050267528 Ginn et al. Dec 2005 A1
20060004408 Morris et al. Jan 2006 A1
20060030886 Clark Feb 2006 A1
20060034930 Khosravi et al. Feb 2006 A1
20060047313 Khanna et al. Mar 2006 A1
20060058844 White et al. Mar 2006 A1
20060100664 Pai et al. May 2006 A1
20060142797 Egnelov Jun 2006 A1
20060173492 Akerfeldt et al. Aug 2006 A1
20060178682 Boehlke Aug 2006 A1
20060206146 Tenerz Sep 2006 A1
20060229672 Forsberg Oct 2006 A1
20060229673 Forsberg Oct 2006 A1
20060229674 Forsberg Oct 2006 A1
20060259074 Kelleher et al. Nov 2006 A1
20060265006 White et al. Nov 2006 A1
20060265007 White et al. Nov 2006 A1
20060265008 Maruyama et al. Nov 2006 A1
20070032823 Tegg Feb 2007 A1
20070032824 Terwey Feb 2007 A1
20070038244 Morris et al. Feb 2007 A1
20070038245 Morris et al. Feb 2007 A1
20070073345 Pipenhagen et al. Mar 2007 A1
20070083231 Lee Apr 2007 A1
20070083232 Lee Apr 2007 A1
20070118176 Opolski et al. May 2007 A1
20070135842 Van de Moer et al. Jun 2007 A1
20070276433 Huss Nov 2007 A1
20080065121 Kawaura et al. Mar 2008 A1
20080071311 White et al. Mar 2008 A1
20080097521 Khosravi et al. Apr 2008 A1
20080109030 Houser et al. May 2008 A1
20080114394 Houser et al. May 2008 A1
20090024106 Morris Jan 2009 A1
20100194110 Ng Aug 2010 A1
Foreign Referenced Citations (8)
Number Date Country
1568326 Aug 2005 EP
1671591 Jun 2006 EP
1949859 Jul 2008 EP
8911301 Nov 1989 WO
2005117715 Dec 2005 WO
2006078578 Jul 2006 WO
2006124238 Nov 2006 WO
2010096483 Aug 2010 WO
Related Publications (1)
Number Date Country
20100217308 A1 Aug 2010 US